| 1. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 2. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 3. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
| 4. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
| 5. | | Recruiting | ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 6. | | Recruiting | ABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 7. | | Recruiting | Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Conditions: Colon Cancer; liver metastases; Rectal Cancer |
| 8. | | Recruiting | AG-013736 as Second-Line Therapy in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 9. | | Recruiting | AG2037 in Treating Patients With Metastatic Cancer of the Colon or Rectum That Has Not Responded to Fluorouracil and Leucovorin
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; adenocarcinoma of the colon; ... |
| 10. | | Recruiting | Alanosine in Treating Patients With Cancer
Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer |
| 11. | | Recruiting | Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer
Conditions: Anal Cancer; perioperative and postoperative complications; Rectal Cancer |
| 12. | | Recruiting | Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; recurrent adult acute lymphoblastic leukemia; ... |
| 13. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer |
| 14. | | Recruiting | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Condition: Graft Versus Host Disease |
| 15. | | Recruiting | beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Conditions: disseminated neuroblastoma; recurrent neuroblastoma |
| 16. | | Recruiting | Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
| 17. | | Recruiting | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 18. | | Recruiting | Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
Conditions: stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ... |
| 19. | | Recruiting | Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
| 20. | | Recruiting | Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Conditions: localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma |
| 21. | | Recruiting | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 22. | | Recruiting | Bortezomib in Treating Patients With Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 23. | | Recruiting | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Conditions: recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach |
| 24. | | Recruiting | CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 25. | | Recruiting | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer |
| 26. | | Recruiting | Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 27. | | Recruiting | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
| 28. | | Recruiting | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Condition: Cancer |
| 29. | | Recruiting | Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
Conditions: adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ... |
| 30. | | Recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma |
| 31. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse small cleaved cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 32. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 33. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Conditions: bone marrow ablation; Cancer |
| 34. | | Recruiting | Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer; Urethral Cancer |
| 35. | | Recruiting | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent childhood lymphoblastic lymphoma; recurrent osteosarcoma; ... |
| 36. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
| 37. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 38. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 39. | | Recruiting | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 40. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions: unspecified adult solid tumor, protocol specific; stage IV prostate cancer; recurrent prostate cancer |
| 41. | | Recruiting | Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases from Colorectal Cancer
Conditions: Colon Cancer; liver metastases; Rectal Cancer |
| 42. | | Recruiting | Combination Chemotherapy Plus Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 43. | | Recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
Conditions: recurrent testicular cancer; recurrent ovarian germ cell tumor; extragonadal germ cell tumor |
| 44. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Conditions: Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ... |
| 45. | | Recruiting | Comparison of Two Induction Combination Chemotherapy Regimens Followed By High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With or Without Rituximab as Maintenance Therapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Condition: recurrent adult diffuse large cell lymphoma |
| 46. | | Recruiting | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer |
| 47. | | Recruiting | CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who are Undergoing Radiation Therapy
Conditions: stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer |
| 48. | | Recruiting | Docetaxel in Treating Older Patients With Metastatic Breast or Lung Cancer
Conditions: stage IV breast cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; recurrent breast cancer |
| 49. | | Recruiting | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Conditions: unspecified adult solid tumor, protocol specific; stage IV esophageal cancer; stage IV gastric cancer |
| 50. | | Recruiting | Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Anthracycline and Taxane Chemotherapy
Conditions: recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
